Clinical Oncology/Epidemiology in 1989

Semen cryopreservation in men undergoing cancer chemotherapy – a UK survey

• DW Milligan
• R Hughes
• KS Lindsay

Evaluation of a model to predict recurrence after radical cystectomy in bilharzial bladder cancer patients

• M Rafla
• AS Ibrahim
• JY Mary

West Midlands Oncology Association trials of adjuvant chemotherapy in operable breast cancer: results after a median follow-up of 7 years. II. Patients without involved axillary lymph nodes

• JM Morrison
• A Howell
• JAH Waterhouse

Recombinant α₂ interferon is superior to doxorubicin for inoperable hepatocellular carcinoma: a prospective randomised trial

• C-L Lai
• P-C Wu
• M Arnold

Weekly epirubicin for breast cancer with liver metastases and abnormal liver biochemistry

• CJ Twelves
• SM O'Reilly
• RD Rubens

A specialist leukaemia/lymphoma registry in the UK. Part 2: clustering of Hodgkin's disease

• FE Alexander
• J Williams
• RA Cartwright

Quantitative magnetic resonance imaging in autologous bone marrow transplantation for Hodgkin's disease

• SR Smith
• CE Williams
• JM Davies

Evaluation of the effect of continuous infusion recombinant interleukin-2 (bioleukin) on peripheral blood leucocytes of patients with terminal malignancy

• RTD Oliver
• D Crosby
• A Galazka

A specialist leukaemia/lymphoma registry in the UK. Part 1: incidence and geographical distribution of Hodgkin's disease

• PA McKinney
• FE Alexander
• RA Cartwright

Serum levels and biochemical characteristics of human ovarian carcinoma-associated antigen defined by murine monoclonal antibody, CF511

• K Ohkawa
• Y Tsukada
• K Mitani

DNA content in high and intermediate grade non-Hodgkin's lymphoma-prognostic significance and clinicopathological correlations

• RA Cowan
• M Harris
• D Crowther

West Midlands Oncology Association trials of adjuvant chemotherapy in operable breast cancer: results after a median follow-up of 7 years. I. Patients with involved axillary lymph nodes

• JM Morrison
• A Howell
• JAH Waterhouse

Symptom relief with moderate dose chemotherapy (mitomycin-C, vinblastine and cisplatin) in advanced non-small cell lung cancer

• JR Hardy
• T Noble
• IE Smith

Cisplatin/carboplatin cross-resistance in ovarian cancer

• ME Gore
• I Fryatt
• AH Calvert

Urinary excretion of prostacyclin and thromboxane degradation products in patients with ovarian malignancy: effect of cytostatic treatment

• A Aitokallio-Tallberg
• L Viinikka
• O Ylikorkala

Minimal neuropsychological sequelae following prophylactic treatment of the central nervous system in adult leukaemia and lymphoma

• J Tucker
• PF Prior
• TA Lister

Primary gastrointestinal non-Hodgkin's lymphoma in a population-based registry

• R Otter
• R Bieger
• R Willemze

First line combination chemotherapy with cisplatin and etoposide in advanced ovarian cancer

• AE Athanassiou
• D Bafaloukos
• V Barbounis

Recombinant interleukin-2 (rIL-2) given intrasplenically and intravenously for advanced malignant melanoma. A phase I and II study

• N Thatcher
• H Dazzi
• RDP Craig

A prospective randomised controlled trial of tamoxifen and cyproterone acetate in pancreatic carcinoma

• JJ Keating
• PJ Johnson
• R Williams